01 September 1998
Increased frequency of defected CYP2D6 gene alleles among children with leukemia in comparison to children with infectious diseases and atopic allergy
Elżbieta Zielińska, Henryk W. Witas, Jerzy BodalskiMed Sci Monit 1998; 4(5): BR756-764 :: ID: 501961
Abstract
The aim of this study was to evaluate the frequency of CYP2D6 gene mutations in Polish children as well as to determine the significance of genotypes encoding poor metabolizer phenotypes in chronic diseases such as atopic allergy and lympho-myeloproliferative diseases. Out of 172 children of which 94 had been treated for acute infectious diseases, 57 presented with atopic allergy and 21 with lympho-myeloproliferative diseases. We isolated DNA from peripheral blood. We identified by means of the allele-specific amplification assay (ASA) followed by analysis of restriction fragment length polymorphism the presence of A 2367 deletion in exon 5 (allele D6-A) and G1934→A transition replacing the junction between intron 3 and exon 4 (allele D6-B), in the CYP2D6 gene. This method allows for the detection of genotypes encoding cytochrome P4502D6 (presence of allele wt) and identifies poor metabolizers which are homozygous or heterozygous for defective D6-A and D6-B alleles. In 5.0% of the studied children we noted genotypes with two defective alleles, which reflects the occurrence of poor metabolizers in other parts of Europe. The frequency of mutations and distribution of genotypes in children with allergies is comparable to results obtained from the control group. However, in children with lymphoproliferative diseases and positive family history of neoplasms, mutated alleles appear statistically significantly more frequently (p< 0.0003). In these children genotypes encoding metabolic defects were identified twice as frequently. The identification of CYP2D6 gene mutations may be useful in the determination of risk factors such as the genetic predisposition to lympho-myeloproliferative diseases.
Keywords: mono-oxygenase cytochrome P450, genotype CYP2D6, children, Allergy, Leukemia
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952